Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers

Clinical trial NCT05248672 · COMPLETED

Trial details

NCT number: NCT05248672
Sponsor: Cognition Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2022-02-15
Primary completion: 2022-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.